A core needle biopsy takes tiny cylinders of tissue from a swollen lymph node — often under ultrasound guidance — to confirm lymphoma and identify its exact subtype. This guide explains the procedure, recovery, results and the tests run on your sample.
A core needle biopsy is a way of sampling a suspicious lymph node using a thin, hollow needle that removes one or more small cylinders — called cores — of tissue. It sits between a fine-needle aspiration (FNA), which draws out only loose cells, and an open surgical biopsy, which removes a whole node. For lymphoma, the amount and structure of tissue matter: pathologists need to see how the cells are arranged, not just what individual cells look like. A well-taken core needle biopsy preserves enough of that architecture to diagnose lymphoma and, crucially, to identify its subtype.
Because many enlarged nodes sit deep in the neck, chest, armpit or abdomen, a core biopsy is often performed as an ultrasound guided node biopsy or, for deeper sites, under CT guidance. Real-time imaging lets the radiologist steer the needle precisely into the node while avoiding nearby vessels and nerves. This is far more reliable than a blind attempt, and it is the reason a needle biopsy lymph node procedure today is usually image-guided.
This page walks through how the biopsy is done, what recovery is like, how long results take and which laboratory tests confirm the diagnosis. For the wider picture, see our Lymphoma hub and, if you already know your diagnosis, our Lymphoma Treatment in Hyderabad page. If you would prefer a whole-node approach, our page on what to expect from a lymph node biopsy explains that route.
Lymphoma cannot be diagnosed from cells alone — its classification depends on tissue architecture plus a panel of marker tests. That is why NCCN and ESMO guidelines favour a tissue biopsy that keeps the node structure intact: an excisional (whole-node) biopsy is the preferred standard, and a core needle biopsy is a good alternative when several adequate cores can be obtained. A fine-needle aspiration (FNA) alone is generally not sufficient to diagnose or subtype lymphoma. (Source: NCCN and ESMO clinical practice guidelines for Hodgkin and non-Hodgkin lymphoma.)
Three ways to sample a node — each gives a different amount of tissue, and lymphoma needs more than most cancers to classify accurately.
| Method | What it takes | Best used when |
|---|---|---|
| Fine-needle aspiration (FNA) | Loose cells only | A quick first look or to rule out infection/spread; usually not enough to diagnose lymphoma on its own |
| Core needle biopsy | Small cores of intact tissue | The node is deep or surgery is risky; several adequate cores can often confirm and subtype lymphoma |
| Excisional (whole-node) biopsy | An entire lymph node | The preferred standard for a first lymphoma diagnosis — maximal tissue and architecture |
The right choice depends on the node's location, your health and how quickly an answer is needed. Read more on why lymphoma often needs the whole node. Guidance follows NCCN and ESMO; individual recommendations vary.
An accurate first biopsy sets up your whole treatment plan. Our focus is getting enough good-quality tissue and the right tests, the first time.
Ultrasound and CT guidance let us target the most informative node accurately and safely — important for deep or awkwardly placed nodes, and the reason an ultrasound guided node biopsy is preferred over a blind attempt.
Every sample goes for the full lymphoma work-up — immunohistochemistry, flow cytometry and, where needed, molecular testing — so the subtype is pinned down, not just "lymphoma".
Because a core sample is smaller than a whole node, having enough tissue matters. Our team checks adequacy at the time of biopsy to reduce the chance of a repeat procedure.
From biopsy to staging to a plan agreed by our tumour board, everything is joined up — and reviewed by specialists like our lymphoma doctors at a dedicated cancer hospital.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Waiting on biopsy results, unsure if your sample was enough, or want a second opinion before treatment? CION's lymphoma team is here.
The procedure is usually done as a day-case appointment and takes about 30–45 minutes. Here is what typically happens for an ultrasound guided node biopsy:
If a node has been picked up incidentally on a scan, our page on an enlarged lymph node found on a scan — what next explains how the team decides which node to sample and when.
A core needle biopsy is a well-tolerated, minimally invasive procedure. Knowing what is normal afterwards helps you recover with confidence.
You may feel pressure rather than sharp pain while cores are taken. Afterwards the site can be sore or bruised for a day or two. You will be asked to press on it briefly, and to avoid heavy lifting for about 24 hours. Paracetamol usually settles any discomfort.
Serious complications are uncommon. The main ones are minor bleeding or bruising, and, rarely, infection. For deep chest or abdominal biopsies there is a small additional risk related to the site, which your radiologist will explain. If you take blood-thinning medication, tell the team in advance — it may need to be paused or adjusted.
Occasionally cores do not contain enough diagnostic tissue, or the subtype cannot be classified with confidence. If that happens, your team may recommend repeating the core biopsy or moving to an excisional (whole-node) biopsy. This is not a failure — it reflects how much tissue lymphoma classification can demand.
The lab tests done after the biopsy are what actually name your lymphoma. Immunohistochemistry detects surface markers such as CD20 and CD30; flow cytometry sorts cells by their markers; and molecular tests can reveal features like cell-of-origin or a "double-hit" (MYC with BCL2) rearrangement in aggressive B-cell lymphomas. Per NCCN and ESMO, this marker information — not the microscope appearance alone — determines the subtype and the treatment path. (Source: NCCN and ESMO lymphoma guidelines.)
A lymphoma diagnosis is a laboratory process, not a single glance under the microscope. After the cores are processed, a panel of tests is run to confirm lymphoma and identify its subtype:
Special stains highlight proteins on the tumour cells — markers such as CD20, CD30 and many others. The pattern of markers tells the pathologist whether the lymphoma is Hodgkin or non-Hodgkin and points to the specific subtype. Read more about how immunohistochemistry identifies your subtype.
This test sorts cells by the markers on their surface, which is especially useful for distinguishing lymphoma types and separating them from reactive (non-cancerous) node changes. Our page on flow cytometry & immunophenotyping explains it in detail.
For some lymphomas, molecular and genetic tests add information about cell-of-origin or high-risk rearrangements. Blood tests such as LDH are also checked, as a high level can signal faster-growing or bulky disease.
A preliminary result may be ready within a few days, but the full, subtype-confirmed report usually takes about one to two weeks. All findings come together in your lymphoma pathology report, which the team explains in plain language.
Once the biopsy confirms lymphoma and its subtype, the focus shifts to staging — working out where the lymphoma is and how extensive it is. This usually involves a PET-CT scan and, for some subtypes, a bone marrow biopsy. If a PET scan is used, its result is often reported using the Deauville score.
All of this is reviewed by CION's multidisciplinary tumour board, which agrees a plan tailored to your subtype, stage and overall health. Depending on the type, treatment may involve chemotherapy, an anti-CD20 monoclonal antibody, radiation therapy (IMRT), or — for some slow-growing lymphomas — a period of careful monitoring known as watch-and-wait. Chemotherapy, antibody therapy, radiation, bone-marrow examination and survivorship care are delivered directly by CION; where a stem-cell transplant or advanced cell therapy is needed, this is coordinated through accredited partner facilities.
Published series report broad survival differences by subtype — for example, Hodgkin lymphoma around 80–90% and diffuse large B-cell lymphoma around 60–70% at five years — but these figures vary considerably by individual, stage and response. Your own outlook is best discussed with your specialist once the subtype and stage are known. Explore your options on our Lymphoma Treatment in Hyderabad page, or read how doctors work out which subtype you have.
Lymphoma diagnosis is nuanced, and a second opinion is especially valuable in a few situations:
CION offers a dedicated, free written second-opinion service on your biopsy and pathology report, with transparent costs explained up front. Request your free second opinion or call 18002028726. You can also compare biopsy routes on our lymph node biopsy — what to expect page.
Get a free written second opinion from CION's lymphoma team — especially valuable if only an FNA was done or the subtype is still unclear.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.A core needle biopsy uses a thin, hollow needle to remove one or more small cylinders (cores) of tissue from an enlarged lymph node or mass, usually under local anaesthetic. Unlike a fine-needle aspiration (FNA) — which pulls out only loose cells — a core needle biopsy keeps the tissue architecture intact, which pathologists need to diagnose lymphoma and identify its subtype. It is often done as an image-guided procedure when a node is deep or hard to feel. At CION, the samples are sent for the full panel of tests — including immunohistochemistry and flow cytometry — that a lymphoma diagnosis requires.
For many patients an adequate core needle biopsy — several good-quality cores from the right node — can confirm lymphoma and its subtype. However, NCCN and ESMO guidelines still regard an excisional (whole-node) biopsy as the preferred standard, because lymphoma diagnosis depends on tissue architecture and some subtypes are difficult to classify on cores alone. A core biopsy is a good first step when surgery is risky, the node is deep, or a fast answer is needed. If the cores are inconclusive, your team may recommend a larger sample. Our lymphoma team reviews adequacy before you leave.
In an ultrasound guided node biopsy, a radiologist uses live ultrasound images to see the lymph node and steer the needle precisely into it, avoiding nearby blood vessels and nerves. The skin is cleaned and numbed with local anaesthetic, a tiny nick is made, and the core needle is advanced under real-time imaging to take several samples. Ultrasound is commonly used for neck, armpit (axillary) and groin nodes; a CT scan may guide biopsies of deeper chest or abdominal nodes. Image guidance improves accuracy and safety, which is why a needle biopsy lymph node procedure is increasingly done this way rather than blind. The appointment usually takes 30–45 minutes.
Most people feel a brief sting from the local anaesthetic injection and then pressure rather than sharp pain during the biopsy itself. You may hear a click as the needle takes each core. Afterwards the site can be sore or bruised for a day or two, and you will be asked to press on it briefly to prevent bleeding. Most patients go home the same day and return to normal activity quickly, avoiding heavy lifting for 24 hours. Serious complications such as significant bleeding or infection are uncommon. If you are on blood thinners, tell the team beforehand — this may need to be adjusted. Ask our team what to expect for your specific node.
A lymphoma diagnosis is rarely made from the biopsy appearance alone. After the tissue is processed, pathologists run a panel of stains and tests — immunohistochemistry, and often flow cytometry and molecular or genetic testing — to confirm lymphoma and pin down the exact subtype. A preliminary result may be ready in a few days, but the complete, subtype-confirmed report typically takes about one to two weeks. Rushing this stage risks an incomplete diagnosis, so the wait reflects thoroughness. Your findings feed into your final pathology report, which the team then explains to you in plain language.
The cores are examined under the microscope and then tested with a panel that identifies the lymphoma subtype. Immunohistochemistry looks for surface markers such as CD20, CD30 and others; flow cytometry sorts cells by their markers; and molecular or genetic tests can detect features like cell-of-origin or a "double-hit" rearrangement in aggressive lymphomas. Together these determine whether the lymphoma is Hodgkin or non-Hodgkin, indolent or aggressive, and which treatment path fits. Because a core needle sample is smaller than a whole node, having enough good-quality tissue matters — which is why adequacy is checked at the time of biopsy. Learn more about how your subtype is identified.
Once the subtype is confirmed, the next step is staging — usually with a PET-CT scan and sometimes a bone marrow biopsy — to see where the lymphoma is and how extensive it is. Blood tests, including LDH, add prognostic information. All of this is reviewed by CION's multidisciplinary tumour board, which agrees a plan tailored to your subtype and stage. Depending on the type, treatment may involve chemotherapy, an anti-CD20 monoclonal antibody, radiation, or careful monitoring (watch-and-wait). You can read about the options on our Lymphoma Treatment in Hyderabad page, or book a free consultation to discuss your report.
Browse our complete guide to lymphoma — symptoms, diagnosis, Hodgkin and non-Hodgkin subtypes, treatment, genetics, prognosis, survivorship and cost. Tap any topic to read more.